Search Results | Blood | American Society of Hematology

1-20 of 76

2 3 4

Sort by

Sort Order Select

Journal Articles

Newest Discoveries Using Next Generation Sequencing Approaches for Minimal Residual Disease

Ash A. Alizadeh, MD PhD

Blood (2020) 136 (Supplement 1): SCI2.

DOI: https://doi.org/10.1182/blood-2020-133040

Published: 2020

Journal Articles

Profiling T-Cell Receptor Diversity and Dynamics during Lymphoma Immunotherapy Using Cell-Free DNA (cfDNA)

Navika D Shukla, Alexander F. M. Craig, MPhil, Brian Sworder, MD PhD, David M. Kurtz, MDPhD, Charles Macaulay, MSc, BA, Andrea Garofalo, BS, BA, Matthew J. Frank, MD PhD, Stefan Alig, MD, George Duran, BA, Youn H. Kim, MD, James Zehnder, MD, Crystal L. Mackall, MD, David B. Miklos, MD PhD, Maximilian Diehn, MD PhD, Michael S. Khodadoust, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2020) 136 (Supplement 1): 49–50.

DOI: https://doi.org/10.1182/blood-2020-141655

Published: 2020

Journal Articles

CD58 Aberrations Limit Durable Responses to CD19 CAR in Large B Cell Lymphoma Patients Treated with Axicabtagene Ciloleucel but Can be Overcome through Novel CAR Engineering

Blood (2020) 136 (Supplement 1): 53–54.

DOI: https://doi.org/10.1182/blood-2020-139605

Published: 2020

Journal Articles

Heterogeneity of Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma

Ivana Spasevska, Sarah Josefsson, PhD MSc, Yngvild Nuvin Blaker, MD PhD, Chloe B. Steen, PhD, Ankush Sharma, PhD, Kushi Kushekhar, PhD MSc, Saskia Meyer, PhD, Arne Kolstad, MD PhD, Klaus Beiske, MD PhD, Harald Holte, MD PhD, Bjørn Østenstad, MD PhD, Eva Kimby, MD PhD, Johanna Olweus, PhD, Kjetil Tasken, PhD, Suzanne Lorenz, PhD, Erlend B. Smeland, PhD MD, Ash A. Alizadeh, MD PhD, Kanutte Huse, PhD, June Helen Myklebust, PhD

Blood (2020) 136 (Supplement 1): 27–28.

DOI: https://doi.org/10.1182/blood-2020-142380

Published: 2020

Journal Articles

Bendamustine, Obinutuzumab and Venetoclax As Induction Therapy for Untreated Mantle Cell Lymphoma

Irl Brian Greenwell, MD, Jeffrey M. Switchenko, PhD MS, Kami J. Maddocks, MD, Brad S. Kahl, MD, Alexander F. M. Craig, MPhil, Ash A. Alizadeh, MD PhD, Pamela B. Allen, MD MSc, Alena Lorretta Marbury, BS, Alicia Escobar, Kelly Valla, PharmD, Miayea Williams, Priya Parikh, Danielle Roberts, PA-C, Jessica J. Neely, PA-C, Alexandra Palmer, NP-C, Kristie A. Blum, MD, Jonathon B. Cohen, MDMS

Blood (2020) 136 (Supplement 1): 33–34.

DOI: https://doi.org/10.1182/blood-2020-141454

Published: 2020

Journal Articles

Recurrent Crebbp Mutations in Follicular Lymphoma Appear Localized to the Committed B-Cell Lineage

Joseph G Schroers-Martin, MD, Joanne Soo, MD, Gabriel Brisou, MD, Florian Scherer, MD, David M. Kurtz, MDPhD, Brian Sworder, MD PhD, Michael S. Khodadoust, MD PhD, Michael C. Jin, BS, Agnès Bru, Chih Long Liu, PhD, Henning Stehr, PhD, Paolo Vineis, PhD, Yasodha Natkunam, MD PhD, Bertrand Nadel, PhD, Maximilian Diehn, MD PhD, Sandrine Roulland, PhD, Ash A. Alizadeh, MD PhD

Blood (2020) 136 (Supplement 1): 30–31.

DOI: https://doi.org/10.1182/blood-2020-142761

Published: 2020

Journal Articles

Short Diagnosis-to-Treatment Interval Is Associated with Higher Levels of Circulating Tumor DNA in Aggressive B-Cell Non-Hodgkin Lymphoma

Stefan Alig, MD, Charles Macaulay, MSc, BA, David M. Kurtz, MD PhD, Ulrich Dührsen, Prof, MD PhD, Andreas Hüttmann, MD, Michael C. Jin, BS, Brian Sworder, MD PhD, Andrea Garofalo, BS, BA, Mohammad Shahrokh Esfahani, Joanne Soo, MD, Florian Scherer, MD, Alexander Craig, MPhil, Olivier Casasnovas, MD, Jason R. Westin, MD, Gianluca Gaidano, MD PhD, Davide Rossi, MD PhD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 491.

DOI: https://doi.org/10.1182/blood-2019-129283

Published: 2019

Journal Articles

Follicular Lymphoma Organoids for Investigating the Tumor Microenvironment

Lisa E Wagar, PhD, Brian Sworder, MD PhD, Michael S. Khodadoust, MD PhD, Mark M Davis, PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 2799.

DOI: https://doi.org/10.1182/blood-2019-131192

Published: 2019

Journal Articles

An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma

Chloe B. Steen, MSc, Bogdan A. Luca, PhD, Mohammad Shahrokh Esfahani, Barzin Y. Nabet, PhD, Brian Sworder, MD PhD, Farshad Farshidfar, MD PhD, Kiarash Shamardani, BA, David M. Kurtz, MD PhD, Chih Long Liu, PhD, Ranjana H Advani, MD, Yasodha Natkunam, MD PhD, June Helen Myklebust, PhD, Maximilian Diehn, MD PhD, Andrew Gentles, PhD, Aaron M Newman, PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 655.

DOI: https://doi.org/10.1182/blood-2019-129461

Published: 2019

Journal Articles

Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy

Brian Sworder, MD PhD, David M. Kurtz, MD PhD, Charles Macaulay, MSc, BA, Matthew J. Frank, MD PhD, Stefan Alig, MD, Andrea Garofalo, BS, BA, Bita Sahaf, PhD, Mohammad Shahrokh Esfahani, Jay Y. Spiegel, MDFRCPC, Jean Oak, MD PhD, Sara Beygi, MD, Michael C. Jin, BS, Jacob J Chabon, Michael S. Khodadoust, MD PhD, Robbie G. Majzner, MD, Crystal L. Mackall, MD, Maximilian Diehn, MD PhD, David B Miklos, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 550.

DOI: https://doi.org/10.1182/blood-2019-129015

Published: 2019

Journal Articles

Towards Non-Invasive Classification of DLBCL Genetic Subtypes By Ctdna Profiling

Mohammad Shahrokh Esfahani, Stefan Alig, MD, David M. Kurtz, MD PhD, Joanne Soo, MD, Michael C. Jin, BS, Charles Macaulay, MSc, BA, Alexander F. M. Craig, MPhil, Andrea Garofalo, BS, BA, Chloe B. Steen, MSc, Florian Scherer, MD, Brian Sworder, MD PhD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 551.

DOI: https://doi.org/10.1182/blood-2019-132069

Published: 2019

Journal Articles

Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA

David M. Kurtz, MD PhD, Joanne Soo, MD, Stefan Alig, MD, Lyron Co Ting Keh, Charles Macaulay, Michael C. Jin, BS, Florian Scherer, MD, Emily G. Hamilton, BS, Chih Long Liu, PhD, Binbin Chen, PhD, Alexander F. M. Craig, MPhil, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 552.

DOI: https://doi.org/10.1182/blood-2019-131267

Published: 2019

Journal Articles

Interim Circulating Tumor DNA As a Prognostic Biomarker in the Setting of Interim PET-Based Adaptive Therapy for DLBCL

Charles Macaulay, MSc, BA, Stefan Alig, MD, David M. Kurtz, MD PhD, Michael C. Jin, BS, Stephen Opat, Joanne Soo, MD, Brian Sworder, MD PhD, Mark S. Hertzberg, MD PhD, Maher K. Gandhi, PhD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 1600.

DOI: https://doi.org/10.1182/blood-2019-131278

Published: 2019

Journal Articles

B-cell lymphomas present immunoglobulin neoantigens

Michael S. Khodadoust, Niclas Olsson, Binbin Chen, Brian Sworder, Tanaya Shree, Chih Long Liu, Lichao Zhang, Debra K. Czerwinski, Mark M. Davis, Ronald Levy, Joshua E. Elias, Ash A. Alizadeh

Blood (2019) 133 (8): 878–881.

DOI: https://doi.org/10.1182/blood-2018-06-845156

Published: 2019

Includes: Supplemental data

Journal Articles

Distinct Chromatin Accessibility Profiles of Lymphoma Subtypes Revealed By Targeted Cell Free DNA Profiling

Mahya Mehrmohamadi, PhD, Mohammad S Esfahani, PhD, Joanne Soo, BS, Florian Scherer, MD, Joseph G Schroers-Martin, MD, Binbin Chen, BS, David M. Kurtz, MDPhD, Emily Hamilton, BS, Chih Long Liu, PhD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MDPhD

Blood (2018) 132 (Supplement 1): 672.

DOI: https://doi.org/10.1182/blood-2018-99-119361

Published: 2018

Journal Articles

Lymphoma Virome Dynamics Revealed By Cell-Free DNA Sequencing

Blood (2018) 132 (Supplement 1): 2861.

DOI: https://doi.org/10.1182/blood-2018-99-119905

Published: 2018

Journal Articles

Clinical Impact of Somatic Copy Number Alterations in Circulating Tumor DNA from Diverse Lymphoma Subtypes

Blood (2017) 130 (Supplement 1): 2747.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.2747.2747

Published: 2017

Journal Articles

Reproducibility of m7-FLIPI Risk Scores in Follicular Lymphoma Using Tumor Biopsies and Blood Specimens

Joanne Soo, BS, Florian Scherer, MD, David M. Kurtz, MD, Joseph G Schroers-Martin, MD, Michael Jin, Alexander Craig, MPhil, Henning Stehr, PhD, Chih Long Liu, PhD, Michael R Green, PhD, Oliver Weigert, MD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MDPhD

Blood (2017) 130 (Supplement 1): 1466.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1466.1466

Published: 2017

Journal Articles

Hierarchy in Somatic Mutations Detected in Circulating and Tissue-Resident Follicular Lymphoma Precursors before Clinical Diagnosis

Joseph G Schroers-Martin, MD, Florian Scherer, MD, Joanne Soo, BS, David M. Kurtz, MD, Chih Long Liu, PhD, Henning Stehr, PhD, Agnès Bru, Yasodha Natkunam, MD PhD, Maximilian Diehn, MD PhD, Bertrand Nadel, PhD, Sandrine Roulland, PhD, Ash A. Alizadeh, MDPhD

Blood (2017) 130 (Supplement 1): 308.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.308.308

Published: 2017

Journal Articles

Circulating Tumor DNA Is a Reliable Measure of Tumor Burden at Diagnosis of Diffuse Large B Cell Lymphoma: An International Reproducibility Study

Blood (2017) 130 (Supplement 1): 310.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.310.310

Published: 2017

2 3 4

NARROW

Newest Discoveries Using Next Generation Sequencing Approaches for Minimal Residual Disease

Profiling T-Cell Receptor Diversity and Dynamics during Lymphoma Immunotherapy Using Cell-Free DNA (cfDNA)

CD58 Aberrations Limit Durable Responses to CD19 CAR in Large B Cell Lymphoma Patients Treated with Axicabtagene Ciloleucel but Can be Overcome through Novel CAR Engineering

Heterogeneity of Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma

Bendamustine, Obinutuzumab and Venetoclax As Induction Therapy for Untreated Mantle Cell Lymphoma

Recurrent Crebbp Mutations in Follicular Lymphoma Appear Localized to the Committed B-Cell Lineage

Short Diagnosis-to-Treatment Interval Is Associated with Higher Levels of Circulating Tumor DNA in Aggressive B-Cell Non-Hodgkin Lymphoma

Follicular Lymphoma Organoids for Investigating the Tumor Microenvironment

An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma

Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy

Towards Non-Invasive Classification of DLBCL Genetic Subtypes By Ctdna Profiling

Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA

Interim Circulating Tumor DNA As a Prognostic Biomarker in the Setting of Interim PET-Based Adaptive Therapy for DLBCL

B-cell lymphomas present immunoglobulin neoantigens

Distinct Chromatin Accessibility Profiles of Lymphoma Subtypes Revealed By Targeted Cell Free DNA Profiling

Lymphoma Virome Dynamics Revealed By Cell-Free DNA Sequencing

Clinical Impact of Somatic Copy Number Alterations in Circulating Tumor DNA from Diverse Lymphoma Subtypes

Reproducibility of m7-FLIPI Risk Scores in Follicular Lymphoma Using Tumor Biopsies and Blood Specimens

Hierarchy in Somatic Mutations Detected in Circulating and Tissue-Resident Follicular Lymphoma Precursors before Clinical Diagnosis

Circulating Tumor DNA Is a Reliable Measure of Tumor Burden at Diagnosis of Diffuse Large B Cell Lymphoma: An International Reproducibility Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only